Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. (2017)

First Author: Brocklebank V
Attributed to:  Personalised management of atypical haemolytic uraemic syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ckj/sfx081

PubMed Identifier: 28980670

Publication URI: http://europepmc.org/abstract/MED/28980670

Type: Journal Article/Review

Volume: 10

Parent Publication: Clinical kidney journal

Issue: 5

ISSN: 2048-8505